Skip navigation
Today, along with Apheris, we're introducing the Antibody Developability Consortium, with AbbVie…
0:00 / 1:30

Today, along with Apheris, we're introducing the Antibody Developability Consortium, with AbbVie…

Ginkgo Bioworks

@Ginkgo40K followers

Visit on X
78 likesDownloadOriginal post

22,752 views

Today, along with Apheris, we're introducing the Antibody Developability Consortium, with AbbVie, argenx, LundbeckUS, and Takeda as founding members. The Consortium helps pharmaceutical and biotech companies predict manufacturability and developability risks earlier by building the field’s largest standardized antibody developability dataset. Read the full press release here:

1 Comment

Comments from the original post on X (Twitter)

  • Robin Roehm's profile picture

    @RoehmRobin

    @apheris_AI @abbvie @argenxglobal @LundbeckUS @TakedaPharma Thanks for the great collaboration!